NXL
Nexalin Technology, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.75
−6.85%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$2.70
- Revenue estimate
- $90.0K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.11
- EPS estimate
- -$0.10
- Revenue actual
- $12.2K
- Revenue estimate
- $90.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -9.2%
- Revenue beats (12Q)
- 2
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.10 | -$0.11 | Miss -10.00% | $12.2K |
| May 8, 2026 | -$0.10 | -$0.11 | Miss -10.00% | $14.9K |
| Mar 25, 2026 | -$0.12 | -$0.13 | Miss -8.33% | $171.9K |
| Nov 14, 2025 | -$0.12 | -$0.13 | Miss -8.33% | $18.1K |
| Mar 14, 2025 | -$0.12 | -$0.28 | Miss -133.33% | $27.2K |
| Nov 8, 2024 | -$0.12 | -$0.23 | Miss -91.67% | $36.0K |
| May 10, 2024 | — | -$0.14 | — | $78.7K |
| Nov 13, 2023 | — | -$0.31 | — | $24.1K |
| Aug 10, 2023 | — | -$0.11 | — | $35.5K |
| Mar 2, 2023 | — | -$0.03 | — | $545.3K |
| Dec 31, 2021 | — | -$0.13 | — | $24.0K |
| Sep 30, 2021 | — | -$0.37 | — | $56.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026